Back to Main

Faculty Detail    
Name WILLIAM MICHAEL GEISLER
 
Campus Address ZRB 216 Zip 0007
Phone  (20-5) -376
E-mail  wgeisler@uab.edu
Other websites
Career Advisor     

Education
Undergraduate  The University of Tennessee    1992  BS Microbiology and Biology 
Medical School  The University of Tennessee    1996  MD 
Residency  The University of Michigan    1999  Internal Medicine Residency 
Graduate  The University of Washington    2000  MPH Epidemiology 
Fellowship  The University of Washington    2002  Infectious Diseases Fellowship 


Faculty Appointment(s)
Appointment Type Department Division Rank
Center  Center for AIDS Research  Center for AIDS Research Professor
Center  General Clinical Research Center  Ctr for Clinical & Translational Sci Professor
Center  General Clinical Research Center  Center for Women's Reproductive Health Professor
Primary  Medicine  Med - Infectious Diseases Professor
Secondary  Epidemiology  Epidemiology Professor

Graduate Biomedical Sciences Affiliations
Genetics, Genomics and Bioinformatics 

Biographical Sketch 
Dr. Geisler is a magna cum laude and Phi Beta Kappa graduate of the University of Tennessee in Knoxville and completed his doctor of medicine degree at the University of Tennessee in Memphis. He later earned a master of public health degree in epidemiology from the University of Washington School of Public Health and Community Medicine in Seattle. Following an internal medicine internship and residency at the University of Michigan in Ann Arbor, Dr. Geisler served a fellowship at the Division of Allergy and Infectious Diseases at the University of Washington. He is board certified in internal medicine and infectious diseases. In addition to his current teaching, clinical, and research activities at the University of Alabama at Birmingham, Dr. Geisler has also served as a consultant to the CDC for several projects, including development of the 2015 CDC STD Treatment Guidelines and he is the Clinical Associate Director of the UAB Medical Scientist Training Program.

Society Memberships
Organization Name Position Held Org Link
American College of Physicians      
American Sexually Transmitted Diseases Association      
American Society for Microbiology      
Chlamydia Basic Research Society      
Infectious Diseases Society of America      



Research/Clinical Interest
Title
Description
His research interests focus on the influence of both biological characteristics of Chlamydia trachomatis and the human host immune-mediated responses on the clinical manifestations and outcomes of urogenital chlamydial infection. His teaching interests include the epidemiology, clinical manifestations, diagnosis, treatment, and prevention of sexually transmitted infections. Dr. Geisler is a teaching faculty for the AL-NC STD/HIV Prevention Training Center. His clinical interests in addition to STDs, include hospital epidemiology, nosocomial infections, and antibiotic resistance.

Selected Publications 
Publication PUBMEDID
SELECTED PUBLICATIONS

1.Geisler WM, Suchland RJ, Rockey DD, Stamm WE. Epidemiology and clinical manifestations of unique Chlamydia trachomatis isolates that occupy nonfusogenic inclusions. J Infect Dis 2001;184:879-884.

2.Geisler WM, Suchland RJ, Whittington WLH, Stamm WE. Quantitative culture of Chlamydia trachomatis: correlation of inclusion-forming units produced in culture with clinical manifestations of urogenital disease. J Infect Dis 2001;184:1350-1354.

3.Geisler WM, Whittington WLH, Suchland RJ, Stamm WE. Epidemiology of anorectal chlamydial and gonococcal infections among men having sex with men in Seattle: utilizing serovar and auxotype strain typing. Sex Transm Dis 2002;29:189-195.

4.Suchland RJ, Geisler WM, Stamm WE. Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp. Antimicrob Agents Chemother 2003;47:636-642.

5.Geisler WM, Suchland RJ, Whittington WLH, Stamm WE. The relationship of serovar to clinical manifestations of urogenital Chlamydia trachomatis infection. Sex Transm Dis 2003;30:160-165.

6.Geisler WM, Hook EW III. 20 clinical pearls: sexually transmitted diseases. Infect Med 2003;20:340-349.

7.Geisler WM. Approaches to the management of uncomplicated genital Chlamydia trachomatis infections. Exp Rev Anti-infective Ther 2004;2:771-785.

8.Geisler WM, Tang J, Wang C, Wilson CM, Kaslow RA. Epidemiological and genetic correlates of incident Chlamydia trachomatis infection in North American adolescents. J Infect Dis 2004;190:1723-1729.

9.Chiang S, Geisler WM, Jackson JR, Rebar RW. Assessing the impact of a comprehensive sexually transmitted disease curriculum on learning outcomes. Am J Obstet Gynecol 2004;191:1822-1827.

10.Wang C, Tang J, Geisler WM, Crowley-Nowick PA, Wilson CM, Kaslow RA. Human leukocyte antigen and cytokine gene variants as predictors of recurrent Chlamydia trachomatis infections in high-risk adolescents. J Infect Dis 2005;191:1084-1092.

11.Geisler WM, Yu S, Hook EW III. Chlamydial and Gonococcal Urethritis in Men without polymorphonuclear leukocytes on Gram stain: implications for diagnostic approach and management. Sex Transm Dis 2005;32:630-634.

12.Wang C, Tang J, Crowley-Nowick PA, Wilson CM, Kaslow RA, Geisler WM. Interleukin (IL)-2 and IL-12 responses to Chlamydia trachomatis infection in adolescents. Clin Exp Immunol 2005;142:548-554.

13.Geisler WM, Chyu L, Kusunoki Y, Upchurch DM, Hook EW III. Health insurance coverage, health care seeking behaviors, and genital chlamydial infection prevalence in young adults. Sex Transm Dis 2006;33:389-396.

14.Geisler WM, Suchland RJ, Stamm WE. Association of Chlamydia trachomatis serovar Ia infection with african american race in a sexually transmitted diseases clinic patient population in Birmingham, Alabama. Sex Transm Dis 2006;33:621-624.

15.Geisler WM, Chow JM, Schachter J, McCormack WM. Pelvic examination findings and Chlamydia trachomatis infection in asymptomatic young women screened with a nucleic acid amplification test.Sex Transm Dis. 2007;34:335-338.

16.Geisler WM. Management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: evidence reviewed for the 2006 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis. 2007;44:S77-83.